|
[1]SCHUPPAN D, AFDHAL NH.Liver cirrhosis[J].Lancet, 2008, 371 (9615) :838-851.
|
|
[2]ZHANG A, SUN H, YAN G, et al.Mass spectrometry-based metabolomics:applications to biomarker and metabolic pathway research[J].Biomed Chromatogr, 2015, 30 (1) :7-12.
|
|
[3]KOHLER I, GIERA M.Recent advances in liquid-phase separations for clinical metabolomics[J].J Sep Sci, 2017, 40 (1) :93-108.
|
|
[4]ALONSO A, MARSAL S, JULIA A.Analytical methods in untargeted metabolomics:state of the art in 2015[J].Front Bioeng Biotechnol, 2015, 3 (23) :23.
|
|
[5]RODRIGUEZ-ALLE M, GURNY R, VEUTHEY JL, et al.Coupling ultra high-pressure liquid chromatography with mass spectrometry:constraints and possible applications[J].J Chromatogr A, 2013, 1292:2-18.
|
|
[6]ZHAO YY, WU SP, LIU S, et al.Ultra-performance liquid chromatography-mass spectrometry as a sensitive and powerful technology in lipidomic applications[J].Chem Biol Interact, 2014, 220:181-192.
|
|
[7]YANG XX, MA H.Research advances in tumor markersof hepatocellular carcinoma[J].J Clin Hepatol, 2016, 32 (4) :811-815. (in Chinese) 杨霄霄, 马红.肝细胞癌肿瘤标志物的研究进展[J].临床肝胆病杂志, 2016, 32 (4) :811-815.
|
|
[8]LIAN MJ, LIU SY.Research advances in the application of metabolomics in identifying markers for hepatocellular carcinoma[J].Chin J Clin Lab Sci, 2014, 32 (8) :600-602. (in Chinese) 练明建, 刘树业.代谢组学在肝细胞肝癌标志物中的研究进展[J].临床检验杂志, 2014, 32 (8) :600-602.
|
|
[9]LI YD, KUANG ZP.Application of metabolomics technology in screening out markers for liver cancer[J].Chin J Oncol Prev Treat, 2015, 7 (4) :300-302. (in Chinese) 黎远冬, 匡志鹏.代谢组学技术在筛选肝癌标志物中的应用[J].中国癌症防治杂志, 2015, 7 (4) :300-302.
|
|
[10]HUANG Q, TAN Y, YIN P, et al.Metabolic characterization of hepatocellular carcinoma using nontargeted tissue metabolomics[J].Cancer Res, 2013, 73 (16) :4992-5002.
|
|
[11]ZHANG A, SUN H, YAN G, et al.Urinary metabolic profiling identifies a key role for glycocholic acid in human liver cancer by ultra-performance liquid chromatography coupled with high-definition mass spectrometry[J].Clin Chim Acta, 2013, 418:86-90.
|
|
[12]CHEN J, WANG W, LV S, et al.Metabonomics study of liver cancer based on ultra performance liquid chromatography coupled to mass spectrometry with HILIC and RPLC separations[J].Anal Chim Acta, 2009, 650 (1) :3-9.
|
|
[13]QIAN X, ZHAN Q, LV L, et al.Steroid hormone profiles plusα-fetoprotein for diagnosing primary liver cancer by liquid chromatography tandem mass spectrometry[J].Clin Chim Acta, 2016, 457:92-98.
|
|
[14]FITIAN AI, NELSON DR, LIU C, et al.Integrated metabolomic profiling of hepatocellular carcinoma in hepatitis C cirrhosis through GC/MS and UPLC/MS-MS[J].Liver Int, 2014, 34 (9) :1428-1444.
|
|
[15]LIAN JS, LIU W, HAO SR, et al.A serum metabonomic study on the difference between alcohol-and HBV-induced liver cirrhosis by ultra performance liquid chromatography coupled to mass spectrometry plus quadrupole time-of-flight mass spectrometry[J].Chin Med J (Engl) , 2011, 124 (9) :1367-1373.
|
|
[16]WANG X, WANG X, XIE G, et al.Urinary metabolite variation is associated with pathological progression of the post-hepatitis B cirrhosis patients[J].J Proteome Res, 2012, 11 (7) :3838-3847.
|
|
[17]YANG T, ZHENG XY, XING F, et al.Serum metabolomic characteristics of patients with liver cirrhotic ascites[J].Integr Med Int, 2014, 1 (1) :135-142.
|
|
[18]TANG YM, WANG JP, BAO WM, et al.Urine and serum metabolomic profiling reveals that bile acids and carnitine may be potential biomarkers of primary biliary cirrhosis[J].Int J Mol Med, 2015, 36 (2) :377-385.
|
|
[19]LIAN JS, LIU W, HAO SR, et al.A serum metabolomic analysis for diagnosis and biomarker discovery of primary biliary cirrhosis and autoimmune hepatitis[J].Hepatobiliary Pancreat Dis Int, 2015, 14 (4) :413-421.
|
|
[20]ZHANG A, SUN H, HAN Y, et al.Urinary metabolic biomarker and pathway study of hepatitis B virus infected patients based on UPLC-MS system[J].PLo S One, 2013, 8 (5) :e64381.
|
|
[21]NIE CY, HAN T, ZHANG L, et al.Cross-sectional and dynamic change of serum metabolite profiling for Hepatitis B-related acute-on-chronic liver failure by UPLC/MS[J].J Viral Hepat, 2014, 21 (1) :53-63.
|
|
[22]LIAN J, LI X, WANG Y, et al.Metabolite variations between acute-on-chronic liver failure and chronic liver failure caused by hepatitis B virus based on ultra-performance liquid chromatography mass spectrometry[J].Biomed Pharmacother, 2016, 84:994-1000.
|
|
[23]GARCA-CANAVERAS JC, DONATO MT, CASTELL JV, et al.Acomprehensive untargeted metabonomic analysis of human steatotic liver tissue by RP and HILIC chromatography coupled to mass spectrometry reveals important metabolic alterations[J].J Proteome Res, 2011, 10 (10) :4825-4834.
|
|
[24]KALHAN SC, GUO L, EDMISON J, et al.Plasma metabolomic profile in nonalcoholic fatty liver disease[J].Metabolism, 2011, 60 (3) :404-413.
|
|
[25]BARR J, VZQUEZ-CHANTADA M, ALONSO C, et al.Liquid chromatography-mass spectrometry-based parallel metabolic profiling of human and mouse model serum reveals putative biomarkers associated with the progression of nonalcoholic fatty liver disease[J].J Proteome Res, 2010, 9 (9) :4501-4512.
|
|
[26]CHEN Y, LI C, LIU L, et al.Serum metabonomics of NAFLD plus T2DM based on liquid chromatography-mass spectrometry[J].Clin Biochem, 2016, 49 (13-14) :962-966.
|
|
[27]SEIJO S, LOZANO JJ, ALONSO C, et al.Metabolomics discloses potential biomarkers for the noninvasive diagnosis of idiopathic portal hypertension[J].Am J Gastroenterol, 2013, 108 (6) :926-932.
|
|
[28]SEIJO S, LOZANO JJ, ALONSO C, et al.Metabolomics as a diagnostic tool for idiopathic non-cirrhotic portal hypertension[J].Liver Int, 2016, 36 (7) :1051-1058.
|
DownLoad: